KYNTRA BIO, INC. (KYNB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 150M 300M 450M Q4 '14: 137.6M Q1 '15: 136M Q2 '15: 166.6M Q3 '15: 172.5M Q4 '15: 180.8M Q1 '16: 192.8M Q2 '16: 161.5M Q3 '16: 172.1M Q4 '16: 183.2M Q1 '17: 184.3M Q2 '17: 125.3M Q3 '17: 135.8M Q4 '17: 131M Q1 '18: 133.5M Q2 '18: 147.2M Q3 '18: 135.6M Q4 '18: 213M Q1 '19: 204.9M Q2 '19: 352.5M Q3 '19: 356.7M Q4 '19: 256.6M Q1 '20: 257.1M Q2 '20: 108.4M Q3 '20: 119.3M Q4 '20: 176.3M Q1 '21: 190.3M Q2 '21: 171.8M Q3 '21: 283.8M Q4 '21: 235.3M Q1 '22: 257.7M Q2 '22: 263.1M Q3 '22: 122.9M Q4 '22: 140.7M Q1 '23: 116.1M Q2 '23: 130.6M Q3 '23: 155M Q4 '24: 29.6M Q1 '25: 7M Q2 '25: 7.3M Q3 '25: 8.3M Q4 '25: 6.4M Q1 '26: 7.4M Q2 '26: 4.6M Q4 '14 Q2 '16 Q4 '17 Q2 '19 Q4 '20 Q2 '22 Q4 '24 Q2 '26

Gross Profit TTM

0 100M 200M 300M Q2 '21: 160.5M Q3 '21: 271.4M Q4 '21: 222.4M Q1 '22: 244M Q2 '22: 245.7M Q3 '22: 104.4M Q4 '22: 120.5M Q1 '23: 96.5M Q2 '23: 112.2M Q3 '23: 136.6M Q4 '25: 5.9M Q1 '26: 3M Q2 '26: 289K Q2 '21 Q4 '21 Q2 '22 Q4 '22 Q2 '23 Q4 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-450M -300M -150M 0 150M 300M 450M Q4 '14: -50.1M Q1 '15: -80.6M Q2 '15: -70.5M Q3 '15: -77.2M Q4 '15: -77.6M Q1 '16: -59.7M Q2 '16: -92.5M Q3 '16: -70.8M Q4 '16: -50M Q1 '17: -52.1M Q2 '17: -108.7M Q3 '17: -109.4M Q4 '17: -117.3M Q1 '18: -129.1M Q2 '18: -122.2M Q3 '18: -142.2M Q4 '18: -86.7M Q1 '19: -94.9M Q2 '19: 41.1M Q3 '19: 31M Q4 '19: -89.3M Q1 '20: -121.5M Q2 '20: -319.5M Q3 '20: -234.3M Q4 '20: -191.9M Q1 '21: -181.2M Q2 '21: -229.9M Q3 '21: -211.3M Q4 '21: -288.5M Q1 '22: -281.1M Q2 '22: -225.5M Q3 '22: -370.1M Q4 '22: -301M Q1 '23: -314.1M Q2 '23: -323.9M Q3 '23: -293.8M Q4 '23: -322.7M Q1 '24: -295.8M Q2 '24: -254.2M Q3 '24: -238.4M Q4 '24: -150.4M Q1 '25: -116.2M Q2 '25: -81.8M Q3 '25: -39.5M Q4 '25: -45.9M Q1 '26: -44.8M Q2 '26: -50.3M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Net Income TTM

-450M -300M -150M 0 150M 300M 450M Q4 '14: -59.5M Q1 '15: -89.6M Q2 '15: -79.4M Q3 '15: -85M Q4 '15: -85.8M Q1 '16: -67.3M Q2 '16: -100M Q3 '16: -79M Q4 '16: -58.1M Q1 '17: -60.8M Q2 '17: -117.1M Q3 '17: -117.4M Q4 '17: -120.9M Q1 '18: -131.7M Q2 '18: -123.2M Q3 '18: -141.3M Q4 '18: -86.4M Q1 '19: -90.4M Q2 '19: 49M Q3 '19: 42.1M Q4 '19: -77M Q1 '20: -109.9M Q2 '20: -311.2M Q3 '20: -228.8M Q4 '20: -189.3M Q1 '21: -182.7M Q2 '21: -231.4M Q3 '21: -214.6M Q4 '21: -290M Q1 '22: -281.5M Q2 '22: -220.1M Q3 '22: -361.6M Q4 '22: -293.7M Q1 '23: -307.2M Q2 '23: -322.2M Q3 '23: -294.2M Q4 '23: -284.2M Q1 '24: -240.5M Q2 '24: -168.3M Q3 '24: -121.8M Q4 '24: -47.6M Q1 '25: -10M Q2 '25: -2.1M Q3 '25: 215.7M Q4 '25: 183.5M Q1 '26: 163.6M Q2 '26: 183.2M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Cost of Revenue TTM

0 7M 14M 21M Q2 '21: 11.3M Q3 '21: 12.4M Q4 '21: 12.9M Q1 '22: 13.7M Q2 '22: 17.4M Q3 '22: 18.5M Q4 '22: 20.3M Q1 '23: 19.5M Q2 '23: 18.4M Q3 '23: 18.4M Q4 '25: 557K Q1 '26: 4.4M Q2 '26: 4.3M Q2 '21 Q4 '21 Q2 '22 Q4 '22 Q2 '23 Q4 '25 Q2 '26

Operating Cash Flow TTM

-450M -300M -150M 0 150M 300M 450M Q4 '14: 22.4M Q1 '15: -4.3M Q2 '15: 4M Q3 '15: -3M Q4 '15: -18.6M Q1 '16: 6.4M Q2 '16: -50M Q3 '16: -13.7M Q4 '16: 7.1M Q1 '17: -2.8M Q2 '17: -67.2M Q3 '17: -83.9M Q4 '17: -66.5M Q1 '18: -71.3M Q2 '18: -86.5M Q3 '18: -59.9M Q4 '18: -76.1M Q1 '19: -21.7M Q2 '19: -15.4M Q3 '19: -51.1M Q4 '19: -78.7M Q1 '20: -160.7M Q2 '20: 17.6M Q3 '20: 43.8M Q4 '20: 81.6M Q1 '21: 96.1M Q2 '21: -80.1M Q3 '21: -34.5M Q4 '21: -82.2M Q1 '22: -45.7M Q2 '22: -52.2M Q3 '22: -148.4M Q4 '22: -145.9M Q1 '23: -239M Q2 '23: -316.6M Q3 '23: -349.2M Q4 '23: -315M Q1 '24: -272.7M Q2 '24: -202M Q3 '24: -125.9M Q4 '24: -138M Q1 '25: -76M Q2 '25: -23.4M Q3 '25: -16.9M Q1 '15 Q3 '16 Q1 '18 Q3 '19 Q1 '21 Q3 '22 Q1 '24 Q3 '25

Free Cash Flow TTM

-450M -300M -150M 0 150M 300M 450M Q4 '14: 14.3M Q1 '15: -10.5M Q2 '15: -1.1M Q3 '15: -7.3M Q4 '15: -20.5M Q1 '16: 3.9M Q2 '16: -52M Q3 '16: -15.1M Q4 '16: 5.9M Q1 '17: -3.8M Q2 '17: -69M Q3 '17: -89M Q4 '17: -75M Q1 '18: -81M Q2 '18: -97.1M Q3 '18: -68.2M Q4 '18: -84.2M Q1 '19: -28.4M Q2 '19: -21.9M Q3 '19: -58.3M Q4 '19: -84.5M Q1 '20: -166.4M Q2 '20: 12.9M Q3 '20: 40.4M Q4 '20: 77.6M Q1 '21: 92.1M Q2 '21: -85.1M Q3 '21: -40.7M Q4 '21: -87.4M Q1 '22: -52M Q2 '22: -57.8M Q3 '22: -153.2M Q4 '22: -149.7M Q1 '23: -241.7M Q2 '23: -319.3M Q3 '23: -351.8M Q4 '23: -317.5M Q1 '24: -274.7M Q2 '24: -203M Q3 '24: -126.2M Q4 '24: -138.3M Q1 '25: -76.2M Q2 '25: -23.7M Q3 '25: -17.1M Q1 '15 Q3 '16 Q1 '18 Q3 '19 Q1 '21 Q3 '22 Q1 '24 Q3 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 35M 70M 105M Q2 '14: 37.1M Q2 '15: 68.8M Q2 '16: 69M Q2 '17: 69.6M Q2 '18: 83.8M Q3 '18: 84.5M Q2 '19: 91.7M Q3 '19: 87M Q2 '20: 89.5M Q3 '20: 93.7M Q2 '21: 92.3M Q3 '21: 92.8M Q1 '22: 93M Q2 '22: 93.5M Q3 '22: 93.8M Q1 '23: 94.7M Q2 '23: 97.7M Q3 '23: 98.2M Q1 '24: 99M Q2 '24: 4M Q3 '24: 4M Q1 '25: 4M Q2 '25: 4M Q3 '25: 4M Q1 '26: 4M Q2 '26: 4M Q2 '15 Q3 '18 Q3 '20 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-20.00 0.00 20.00 40.00 60.00 Q4 '14: -6.08 Q1 '15: -5.63 Q2 '15: -5.38 Q3 '15: -3.19 Q4 '15: -1.54 Q1 '16: -1.21 Q2 '16: -1.69 Q3 '16: -1.33 Q4 '16: -0.97 Q1 '17: -1.00 Q2 '17: -1.83 Q3 '17: -1.77 Q4 '17: -1.70 Q1 '18: -1.72 Q2 '18: -1.52 Q3 '18: -1.70 Q4 '18: -1.03 Q1 '19: -1.06 Q2 '19: 0.48 Q3 '19: 0.41 Q4 '19: -0.89 Q1 '20: -1.25 Q2 '20: -3.46 Q3 '20: -2.54 Q4 '20: -2.14 Q1 '21: -2.03 Q2 '21: -2.53 Q3 '21: -2.34 Q4 '21: -3.14 Q1 '22: -3.04 Q2 '22: -2.37 Q3 '22: -3.89 Q4 '22: -3.15 Q1 '23: -3.28 Q2 '23: -3.40 Q3 '23: -3.07 Q4 '23: -2.93 Q1 '24: -2.45 Q2 '24: -5.44 Q3 '24: -9.04 Q4 '24: -11.89 Q1 '25: -10.41 Q2 '25: -8.40 Q3 '25: 45.46 Q4 '25: 45.37 Q1 '26: 40.46 Q2 '26: 45.30 Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.